SAB Biotherapeutics, Inc. (SABS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -14.27M | -16.78M | -13.05M | -7.15M | -7.8M | -9.27M | -6.29M | -7.79M | -10.92M | -13.45M | -5.17M | -4.9M | -1.61M | 216.72K | -8.17M | -4.45M | -9.54M | -4.88M | 3.8M | -6.39M |
| Operating CF Margin % | - | - | - | - | - | -8083.04% | - | -2959.1% | -1155.8% | -4408.6% | -407.88% | -5728.8% | -276.32% | 10.03% | -227.7% | -70.04% | -80.81% | -44.11% | 25.87% | -35.07% |
| Operating CF Growth % | -83.03% | -80.95% | -107.41% | 8.15% | 28.58% | 31.05% | -21.75% | -58.94% | -579.91% | -6304.59% | 36.77% | -10.14% | 83.16% | 104.44% | -315.24% | 30.35% | -200.89% | - | - | - |
| Net Income | -18.87M | -16.86M | 5.34M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.87M | -7.08M | -4.78M | 985.86K | -11.55M | -4.06M | -2.94M |
| Depreciation & Amortization | 752.67K | 763.3K | 765.47K | 774.52K | 778.3K | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 781K | 677.44K | 661.19K | 415.04K | 300.15K |
| Stock-Based Compensation | 0 | 3.17M | 0 | 627.2K | 612.95K | 0 | 1.05M | 601.43K | 617.45K | 536.88K | 639.25K | 644.82K | 602.78K | 628.54K | 0 | 569.86K | 897.6K | 651.47K | 880.66K | 433.43K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.53M | 0 | 357.52K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.91M | 3.47M | -20.78M | 618.21K | -5.06M | 3.22M | -54.53K | -2.34M | -5.72M | 10.89M | -195.47K | 50K | 10.94K | -68.81K | -206.28K | -1.73M | -7.86M | 4.49M | 0 | -1.5K |
| Working Capital Changes | -2.06M | -7.32M | 1.62M | 942.8K | 1.06M | -1.88M | 2.1M | 263.34K | -2.77M | -427.41K | -1.49M | 37.13K | 4.21M | 6.61M | -1.8M | 707.17K | -4.23M | 871.27K | 6.56M | -4.18M |
| Change in Receivables | -608.28K | -386.83K | -559.95K | 21.39K | 33.57K | 42.09K | 127.88K | 193.23K | -193.23K | 0 | 361.74K | 401.39K | 4.79M | 7.39M | -3.33M | 2.17M | -3.78M | 2.2M | 6.9M | -5.52M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -268.42K | -278.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 114.12K | 324.53K | 335.92K | 138.17K | 684.17K | 590.38K | 134.62K | -45.04K | 243.36K | -105.77K | -320.68K | -41.11K | -2.23M | -1.81M | 540.69K | -37.76K | 522.82K | 0 | -1.4M | 1.95M |
| Cash from Investing | -65.65M | -1.71M | -129.87M | 5.2M | 4.67M | 9.33M | -1.15M | 11.22M | -31.36M | -67.86K | -40.86K | -22.68K | -21.3K | -117.75K | -78.5K | -612.83K | -1.28M | -2.36M | -3.23M | -3.46M |
| Capital Expenditures | -983.26K | -933.16K | 0 | 0 | 0 | -55.38K | -100.3K | -52.51K | -129.07K | -67.86K | -85.31K | -22.68K | -21.3K | -117.75K | -78.5K | -612.83K | -1.36M | -2.36M | -3.23M | -3.46M |
| CapEx % of Revenue | - | - | - | - | - | 48.28% | - | 19.96% | 13.66% | 22.25% | 6.73% | 26.53% | 3.67% | 5.45% | 2.19% | 9.65% | 11.5% | 21.36% | 21.99% | 19.02% |
| Acquisitions | 2.22K | 0 | 0 | 0 | 500 | 0 | 0 | 0 | 0 | 0 | 44.45K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76.39K | 0 | 0 | 0 |
| Cash from Financing | 89.92M | -41.69K | 168.69M | -173.84K | -173.99K | -44.14K | -674.13K | -252.33K | -227.03K | 67.64M | -140.31K | -363.79K | -359.79K | 6.62M | -32.17K | -731.04K | -6.32M | 36.03M | -51.23K | -46.23K |
| Debt Issued (Net) | -37.39K | -168.77M | 168.69M | -173.84K | -171.91K | -19.21K | -649.13K | -252.33K | -247.44K | 477.76K | -142.74K | -363.79K | -361.68K | -1.07M | -32.17K | -800.18K | -804.53K | -1.15M | -51.23K | -46.23K |
| Equity Issued (Net) | 89.96M | 168.73M | 0 | 0 | 0 | -3 | 0 | 0 | 20.41K | 67.16M | 2.43K | 0 | 0 | 7.68M | 1 | 0 | -5.52M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.52M | 0 | 0 | 0 |
| Other Financing | -4.57K | -5.01K | -4.88K | 0 | -2.07K | -24.93K | -25K | 0 | 0 | 0 | 0 | 0 | 1.89K | -1 | 0 | 69.14K | 7.83K | 37.19M | 0 | 0 |
| Net Change in Cash | 10.02M | -18.92M | 25.73M | -1.95M | -3.26M | -273.21K | -8.07M | 3.21M | -42.53M | 54.14M | -5.35M | -5.29M | -1.99M | 6.71M | -8.28M | -5.79M | -17.14M | 28.79M | 518.09K | -9.9M |
| Free Cash Flow | -15.25M | -17.71M | -13.05M | -7.15M | -7.8M | -9.33M | -6.39M | -7.84M | -11.05M | -13.51M | -5.25M | -4.92M | -1.63M | 98.97K | -8.25M | -5.06M | -10.9M | -7.24M | 569.32K | -9.85M |
| FCF Margin % | - | - | - | - | - | -8131.32% | - | -2979.06% | -1169.47% | -4430.85% | -414.61% | -5755.33% | -279.99% | 4.58% | -229.88% | -79.69% | -92.31% | -65.47% | 3.88% | -54.09% |
| FCF Growth % | -95.64% | -89.89% | -104.15% | 8.77% | 29.41% | 30.99% | -21.69% | -59.27% | -578.94% | -13755.51% | 36.34% | 2.75% | 85.07% | 101.37% | -1549.49% | 48.62% | -244.05% | - | - | - |
| FCF per Share | -0.28 | -0.29 | -0.17 | -0.77 | -0.84 | -1.01 | -0.69 | -0.85 | -1.20 | -2.28 | -1.00 | -0.98 | -0.32 | 0.02 | -1.92 | -1.18 | -2.38 | -1.67 | 0.13 | -2.27 |
| FCF Conversion (FCF/Net Income) | 0.76x | 0.99x | -0.29x | 0.71x | 1.50x | 0.81x | 0.61x | 1.06x | 2.17x | 0.59x | 1.01x | 0.71x | 0.22x | -0.03x | 1.16x | 0.93x | -9.67x | 0.42x | -0.94x | 2.17x |
| Interest Paid | 0 | 0 | 0 | 64.8K | 0 | 0 | 154.21K | 0 | 0 | 0 | 0 | 0 | 78.31K | 158.32K | 0 | 71.24K | 72.02K | 0 | 78.56K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |